GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 65 filers reported holding GAMIDA CELL LTD in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,968 | -46.7% | 24,241 | -0.2% | 0.00% | – |
Q2 2023 | $46,862 | +1803.4% | 24,281 | +698.7% | 0.00% | – |
Q1 2023 | $2,462 | – | 3,040 | +645.1% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 408 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 408 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -75.0% | 408 | -55.1% | 0.00% | – |
Q1 2022 | $4,000 | -73.3% | 908 | -85.0% | 0.00% | – |
Q4 2021 | $15,000 | +114.3% | 6,042 | +221.4% | 0.00% | – |
Q3 2021 | $7,000 | -41.7% | 1,880 | 0.0% | 0.00% | – |
Q2 2021 | $12,000 | -20.0% | 1,880 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | – | 1,880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
Platform Technology Partners | 45,375 | $291,000 | 0.12% |
PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |